Mezlocillin information

Mezlocillin
Clinical data
AHFS/Drugs.com	Micromedex Detailed Consumer Information
Pregnancy; category	B;
Routes of; administration	Intravenous, intramuscular
ATC code	J01CA10 (WHO) ;
Pharmacokinetic data
Protein binding	16–59%
Metabolism	Hepatic (20–30%)
Elimination half-life	1.3–4.4 hours
Excretion	Renal (50%) and biliary
Identifiers
	IUPAC name (2S,5R,6R)-3,3-dimethyl-6-[[(2R)-2-[(3-methylsulfonyl-; 2-oxo-imidazolidine-1-carbonyl)amino]-2-phenyl-acetyl]; amino]-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-; carboxylic acid;
CAS Number	51481-65-3 ;
PubChem CID	656511;
DrugBank	DB00948 ;
ChemSpider	570894 ;
UNII	OH2O403D1G;
KEGG	D05021 ;
ChEBI	CHEBI:6919 ;
ChEMBL	ChEMBL1731 ;
CompTox Dashboard (EPA)	DTXSID1023316 ;
ECHA InfoCard	100.052.013
Chemical and physical data
Formula	C21H25N5O8S2
Molar mass	539.58 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C(O)[C@@H]3N4C(=O)[C@@H](NC(=O)[C@@H](c1ccccc1)NC(=O)N2C(=O)N(S(=O)(=O)C)CC2)[C@H]4SC3(C)C;
	InChI InChI=1S/C21H25N5O8S2/c1-21(2)14(18(29)30)26-16(28)13(17(26)35-21)22-15(27)12(11-7-5-4-6-8-11)23-19(31)24-9-10-25(20(24)32)36(3,33)34/h4-8,12-14,17H,9-10H2,1-3H3,(H,22,27)(H,23,31)(H,29,30)/t12-,13-,14+,17-/m1/s1 ; Key:YPBATNHYBCGSSN-VWPFQQQWSA-N ;
	(verify)

Mezlocillin is a broad-spectrum penicillin antibiotic. It is active against both Gram-negative and some Gram-positive bacteria. Unlike most other extended spectrum penicillins, it is excreted by the liver, therefore it is useful for biliary tract infections, such as ascending cholangitis.

Mezlocillin information

and 16 Related for: Mezlocillin information

Mezlocillin

Timeline of antibiotics

Azlocillin

Ureidopenicillin

Penicillin

List of antibiotics

Peptococcus

Benzathine benzylpenicillin

Side effects of penicillin

Pseudomonas aeruginosa

Avibactam

ATC code J01

Cefozopran

David Hager

Epicillin

Carumonam

Clinical data

AHFS/Drugs.com	Micromedex Detailed Consumer Information
Pregnancy category	B
Routes of administration	Intravenous, intramuscular
ATC code	J01CA10 (WHO)
Pharmacokinetic data
Protein binding	16–59%
Metabolism	Hepatic (20–30%)
Elimination half-life	1.3–4.4 hours
Excretion	Renal (50%) and biliary
Identifiers
IUPAC name (2S,5R,6R)-3,3-dimethyl-6-[[(2R)-2-[(3-methylsulfonyl- 2-oxo-imidazolidine-1-carbonyl)amino]-2-phenyl-acetyl] amino]-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2- carboxylic acid
CAS Number	51481-65-3^Y
PubChem CID	656511
DrugBank	DB00948^Y
ChemSpider	570894^Y
UNII	OH2O403D1G
KEGG	D05021^Y
ChEBI	CHEBI:6919^Y
ChEMBL	ChEMBL1731^Y
CompTox Dashboard (EPA)	DTXSID1023316
ECHA InfoCard	100.052.013
Chemical and physical data
Formula	C₂₁H₂₅N₅O₈S₂
Molar mass	539.58 g·mol⁻¹
3D model (JSmol)	Interactive image
SMILES O=C(O)[C@@H]3N4C(=O)[C@@H](NC(=O)[C@@H](c1ccccc1)NC(=O)N2C(=O)N(S(=O)(=O)C)CC2)[C@H]4SC3(C)C
InChI InChI=1S/C21H25N5O8S2/c1-21(2)14(18(29)30)26-16(28)13(17(26)35-21)22-15(27)12(11-7-5-4-6-8-11)23-19(31)24-9-10-25(20(24)32)36(3,33)34/h4-8,12-14,17H,9-10H2,1-3H3,(H,22,27)(H,23,31)(H,29,30)/t12-,13-,14+,17-/m1/s1^Y Key:YPBATNHYBCGSSN-VWPFQQQWSA-N^Y
(verify)